Published in Cancer Res on March 24, 2016
Overexpression of heparanase attenuated TGF-β-stimulated signaling in tumor cells. FEBS Open Bio (2017) 0.75
The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression. Neoplasia (2017) 0.75
The prognostic significance of heparanase expression in metastatic melanoma. Oncotarget (2016) 0.75
Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol (2007) 7.75
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature (1999) 6.50
Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med (1999) 4.22
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med (2010) 3.44
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol (2006) 3.24
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature (2015) 3.24
Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell (2002) 3.11
Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med (1999) 3.06
Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta (2001) 2.74
Id proteins in cell growth and tumorigenesis. Cancer Cell (2003) 2.38
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des (2007) 2.14
Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol (2004) 2.13
The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy. Cell (2014) 2.06
The rationale for targeting the LOX family in cancer. Nat Rev Cancer (2012) 2.02
Denervation suppresses gastric tumorigenesis. Sci Transl Med (2014) 1.96
Mammalian heparanase: what is the message? J Cell Mol Med (2007) 1.91
Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo. Cancer Res (2003) 1.88
The Id proteins and angiogenesis. Oncogene (2001) 1.70
Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem (1999) 1.69
Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun (2000) 1.59
Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy. Cancer Res (2015) 1.59
Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun (1999) 1.56
Significance of heparanase in cancer and inflammation. Cancer Microenviron (2011) 1.46
Heparanase, a potential regulator of cell-matrix interactions. Trends Biochem Sci (2000) 1.45
Lysyl oxidase as a potential therapeutic target. Drug News Perspect (2008) 1.40
Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression. Cancer Res (2008) 1.35
Id genes and proteins as promising targets in cancer therapy. Trends Mol Med (2004) 1.33
The heparanase system and tumor metastasis: is heparanase the seed and soil? Cancer Metastasis Rev (2011) 1.28
Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival. Neoplasia (2006) 1.28
Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase. J Biol Chem (2005) 1.27
Mutations in HPSE2 cause urofacial syndrome. Am J Hum Genet (2010) 1.24
Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity. J Biol Chem (2010) 1.19
Loss-of-function mutations in HPSE2 cause the autosomal recessive urofacial syndrome. Am J Hum Genet (2010) 1.10
Tumorigenic and adhesive properties of heparanase. Semin Cancer Biol (2010) 1.10
The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics. Front Oncol (2014) 1.08
Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins. Mol Cancer Ther (2002) 0.99
Heparanase cooperates with Ras to drive breast and skin tumorigenesis. Cancer Res (2014) 0.99
Heparanase induces signal transducer and activator of transcription (STAT) protein phosphorylation: preclinical and clinical significance in head and neck cancer. J Biol Chem (2011) 0.98
Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways. Oncogene (2014) 0.91
Heparanase enhances myeloma progression via CXCL10 downregulation. Leukemia (2014) 0.90
Muscle composition is regulated by a Lox-TGFβ feedback loop. Development (2015) 0.87
Processing of heparanase is mediated by syndecan-1 cytoplasmic domain and involves syntenin and α-actinin. Cell Mol Life Sci (2014) 0.87
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis. Proc Natl Acad Sci U S A (2016) 0.85
The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation. J Biol Chem (2011) 0.85
Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Hum Pathol (2011) 0.84
A new role for LOX and LOXL2 proteins in transcription regulation. FEBS J (2014) 0.84
Urofacial syndrome: a genetic and congenital disease of aberrant urinary bladder innervation. Pediatr Nephrol (2013) 0.84
High expression of heparanase-2 is an independent prognostic parameter for favorable survival in gastric cancer patients. Cancer Epidemiol (2013) 0.83
Silencing Id-1 inhibits lymphangiogenesis through down-regulation of VEGF-C in oral squamous cell carcinoma. Oral Oncol (2010) 0.82
Heparanase 2, mutated in urofacial syndrome, mediates peripheral neural development in Xenopus. Hum Mol Genet (2014) 0.82
Intratumoral vessel density as prognostic factors in head and neck squamous cell carcinoma: a meta-analysis of literature. Head Neck (2013) 0.81
Mechanisms of cyst formation in metastatic lymph nodes of head and neck squamous cell carcinoma. Diagn Pathol (2012) 0.81
Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas. Med Oncol (2011) 0.80
Urinary tract effects of HPSE2 mutations. J Am Soc Nephrol (2014) 0.80
A mouse model of urofacial syndrome with dysfunctional urination. Hum Mol Genet (2014) 0.79
Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy. Cancer Res (2015) 1.59
Heparanase cooperates with Ras to drive breast and skin tumorigenesis. Cancer Res (2014) 0.99
Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage. Oncotarget (2016) 0.77
The prognostic significance of heparanase expression in metastatic melanoma. Oncotarget (2016) 0.75